Abstract
The purpose of this study was to determine whether the serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level could be a useful marker for Kawasaki disease in the pediatric emergency department (PED) and in the presence of fever duration of 4 days or less (hyper-acute phase of Kawasaki disease). Medical records of patients who were 1 month to 15 years old of age and presented at the PED with suspected Kawasaki disease from January 1, 2010, to December 31, 2014, were collected retrospectively. Two hundred thirty-nine patients with a history of fever for 4 days or less were diagnosed with Kawasaki disease, as well as 111 patients with other febrile diseases, and were enrolled. The NT-proBNP level was significantly higher in patients with Kawasaki disease (Kawasaki disease vs. other febrile disease group, 444.8 (189.7–951.5) vs. 153.4 (68.9–287.6) pg/mL; p < 0.001), and a cutoff value of 244.7 pg/mL yielded a sensitivity and specificity of 68.6 and 70.3 %, respectively. The area under the curve of the NT-proBNP for predicting Kawasaki disease was 0.763 (95 % CI 0.712–0.814).
Conclusion: NT-proBNP might be an adjunctive laboratory marker for hyper-acute phase of Kawasaki disease in the PED.
What is Known: |
• N-terminal pro-brain natriuretic peptide level has been reported as a useful marker for diagnosis in patients with the acute phase of Kawasaki disease. |
• But, in the cases of less than 5 days of fever, the appropriate level of NT-proBNP for differentiating Kawasaki disease in PED has not been yet evaluated. |
What is New: |
• NT-proBNP might be an adjunctive laboratory marker for hyper-acute phase of Kawasaki disease. |
Similar content being viewed by others
Abbreviations
- AUC:
-
Area under curve
- CI:
-
Confidence interval
- NT-proBNP:
-
N-terminal pro-brain natriuretic peptide
- PED:
-
Pediatric emergency department
- ROC:
-
Receiver operating characteristic
- SD :
-
Standard deviation
References
Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ (2011) Adjunctive laboratory marker of Kawasaki disease; NT-proBNP or hs-CRP? Ann Clin Lab Sci 41:360–363
Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M (2009) Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 30:810–817. doi:10.1007/s00246-009-9441-2
Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, Takahashi M, Bierman FZ, Karchmer AW, Wilson W (1993) Diagnosis and therapy of Kawasaki disease in children. Circulation 87:1776–1780
Diagnostic guidelines for Kawasaki disease. Circulation 103:335–6.
Iwashima S, Ishikawa T (2013) B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease. World J Pediatr 9:239–244. doi:10.1007/s12519-013-0402-8
Kaneko K, Yoshimura K, Tsuji S (2014) Brain natriuretic peptide as a novel diagnostic biomarker in Kawasaki disease. J Compr Ped 5:e19505
Kim DS (2006) Kawasaki disease. Yonsei Med J 47:759–772
McNeal-Davidson A, Fournier A, Spigelblatt L, Saint-Cyr C, Mir TS, Nir A, Dallaire F, Cousineau J, Delvin E, Dahdah N (2012) Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease. Pediatr Int: Off J Jpn Pediatr Soc 54:627–633. doi:10.1111/j.1442-200X.2012.03609.x
Mentz RJ, Felker GM (2011) Natriuretic peptide-guided therapy for heart failure. Circ J 75:2031–2037
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert K (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733. doi:10.1542/peds.2004-2182
Nigrovic LE, Nigrovic PA, Harper MB, Chiang VW (2006) Extreme thrombocytosis predicts Kawasaki disease in infants. Clin Pediatr (Phila) 45:446–452. doi:10.1177/0009922806289621
Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS (2009) NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 30:3–8. doi:10.1007/s00246-008-9258-4
No SJ, Kim DO, Choi KM, Eun LY (2013) Do predictors of incomplete Kawasaki disease exist for infants? Pediatr Cardiol 34:286–290. doi:10.1007/s00246-012-0440-3
Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK (2016) Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. Rheumatol Int 36:551–559
Sanchez-Manubens J, Bou R, Anton J (2014) Diagnosis and classification of Kawasaki disease. J Autoimmun 48-49:113–117. doi:10.1016/j.jaut.2014.01.010
Shiraishi M, Fuse S, Mori T, Doyama A, Honjyo S, Hoshino Y, Hoshino E, Kawaguchi A, Kuroiwa Y, Hotsubo T (2013) N-terminal pro-brain natriuretic peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J 77:2097–2101
Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS (2006) Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 366:304–308. doi:10.1016/j.cca.2005.11.005
Wood LE, Tulloh RMR (2009) Kawasaki disease in children. Heart 95:787–792. doi:10.1136/hrt.2008.143669
Authors’ contributions
Hyuksool Kwon carried out the initial analyses, drafted the initial manuscript, and approved the final manuscript as submitted. Jin Hee Lee performed the data collection, drafted the initial manuscript, and approved the final manuscript as submitted. Jae Yun Jung, Do Kyun Kim, Jin Hee Jung, Ikwan Chang, and Kyuseok Kim reviewed and revised the manuscript and approved the final manuscript as submitted. Young Ho Kwak conceptualized and designed the study, supervised the data collection, reviewed and revised the manuscript, and approved the final manuscript as submitted.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no competing interests.
Funding source
The authors have no financial relationships relevant to this article to disclose.
Financial disclosure
The authors have nothing to disclose.
Rights and permissions
About this article
Cite this article
Kwon, H., Lee, J.H., Jung, J.Y. et al. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease. Eur J Pediatr 175, 1997–2003 (2016). https://doi.org/10.1007/s00431-016-2798-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-016-2798-3